Multicenter study of the clinicopathological features and recurrence risk prediction model of early-stage breast cancer with low-positive human epidermal growth factor receptor 2 expression in China (Chinese Society of Breast Surgery 021)

BACKGROUND: : Breast cancer with low-positive human epidermal growth factor receptor 2 (HER2) expression has triggered further refinement of evaluation criteria for HER2 expression. We studied the clinicopathological features of early-stage breast cancer with low-positive HER2 expression in China an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Ling, Wu, Qian, Zhan, Chongming, Qin, Hongyan, Xiang, Hongyu, Xu, Ling, Ye, Jingming, Duan, Xuening, Liu, Yinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276244/
https://www.ncbi.nlm.nih.gov/pubmed/35274907
http://dx.doi.org/10.1097/CM9.0000000000002056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276244/
https://www.ncbi.nlm.nih.gov/pubmed/35274907
http://dx.doi.org/10.1097/CM9.0000000000002056

Ejemplares similares